A yammacin ranar 11 ga Oktoba, Qingdao Jianma Gene Technology Co., Ltd. (wanda ake kira "Jianma Gene"), wani kamfani ne na Qingdao nede Biotechnology Co., Ltd. (Lambar hannun jari: 800757), wanda ya kasance. da aka jera a cibiyar kasuwanci ta shudin teku ta Qingdao, ta sami buƙatun samfurin bututun samfurin Qingdao.Nan da nan kamfanin ya haɗa albarkatun duk bangarorin tare da sanya shi cikin yanayin "yaƙi" a cikin ƙasa da sa'o'i 20 kusan 100000 samfuran samfuran ƙwayoyin cuta an samar da su.Bututun samfurin kwayar cutar ya cika bukatun sabon coronavirus nucleic acid 10 a cikin 1 gaurayawan tattarawa da kuma gano takamaiman fasaha na Majalisar Jiha, kuma ana iya amfani da shi don gano acid nucleic na kusan mutane miliyan daya, wanda ke haɓaka ingancin ganowa kuma yana taimaka wa Qingdao don yaƙar. "annoba" ta hanyar kimiyya da fasaha.
Bututun samfurin ƙwayar cuta mai yuwuwa wanda Jianma Gene ya samar
Dong Xuefeng, babban manajan Jianma Gene ya ce, "A halin yanzu, duk birnin yana cikin tashin hankali, kuma Qingdao tana gaggauta tattara albarkatu daga daukacin kasar. A matsayinmu na 'yan gida a Qingdao, ya zama wajibi a gare mu mu ba da cikakken goyon baya ga yaki da annobar." Dong Xuefeng, babban manajan kamfanin Jianma Gene. , ya ce tun lokacin da kamfanin ya sami buƙatun gaggawa daga bututun samfuri da yawa, kamfanin ya tattara ma'aikata, kayan aiki da sauran albarkatu duk dare don hanzarta aiwatar da samarwa da samar da kayan aiki na kari.Dukkanin ma'aikata da kayan aiki suna cikin wuri da wuri-wuri.Yana ɗaukar ƙasa da sa'o'i 20 kawai daga karɓar sanarwar zuwa kammala aikin.Bayan an shirya samfuran, ana aika su zuwa wuraren yin samfur na farko a cikin batches don amfani.
An yi amfani da bututun samfurin kwayar cutar da Jianma Gene ta samar a wurin ganowa
Bayan tattara swabs na nasopharyngeal a kowane wurin ganowa, an sanya swabs a cikin bututun adana ƙwayoyin cuta kuma an kai su zuwa cibiyar ganowa don haɓakar acid nucleic da gano haɓakawa.An kirkiro kwayar cutar Jianma Gene a farkon matakin cutar a kasar Sin, wacce za ta iya kashe kwayar cutar da sauri wacce za ta iya kasancewa a cikin samfuran swab na hanci / pharyngeal, kuma ta sami kundin rikodin na'urar likitanci da lasisin samarwa.A m hakar reagent tare da ayyuka na Jianma Gene, cutar inactivation da kuma nucleic acid cleavage ne ɓullo da lokaci guda, wanda zai iya kauce wa na biyu gurbatawa lalacewa ta hanyar capping.Samfurin yana da sauƙin aiki, kuma ana saka swab kai tsaye a cikin reagent bayan an yi samfura, ba tare da ƙarin aikin haƙon acid nucleic ba.Ana sarrafa samfurin a cikin mintuna 3.Za'a iya amfani da samfurin DNA / RNA da aka sarrafa kai tsaye a cikin RT-PCR da ASEA da sauran fasahohin haɓaka acid na nucleic da kansu waɗanda kamfani suka haɓaka, wanda ke ba da damar yin amfani da wurin gano gaggawa da saurin amsa sakamakon gwaji.
Baya ga bututun samfurin kwayar cutar da aka yi amfani da shi a cikin gano ma'aikatan gabaɗaya, Jianma Gene ya sami nasarar haɓaka sabon kayan gano ƙwayar ƙwayar cuta ta coronavirus a cikin Fabrairu na wannan shekara, wanda zai iya fahimtar haɓakar sabon coronavirus a cikin mintuna 30.Hakanan yana ɗaya daga cikin ƙananan masana'antu a duniya waɗanda za su iya kammala gano haɓakawa cikin rabin sa'a.
Nucleic acid kwararre mai saurin ganowa
Email: navid@naidesw.com
Lambar waya: 0532-88330805
Lokacin aikawa: Nov-11-2020
